Weight Loss

Weight Loss Medication Options

Oral and injectable options with personalized medical management.

Oral Options

Wegovy® Pill

Semaglutide • GLP-1

Once-daily oral prescription medication for weight management.

Available Doses & Self-Pay Pricing

DoseSelf-Pay Price
  • 1.5 mg$149
  • 4 mg$199
  • 9 mg$299
  • 25 mg$299

Prescription required • Eligibility determined after medical evaluation

Foundayo™

Orforglipron • GLP-1

Once-daily oral prescription medication for weight management.

Available Doses & Self-Pay Pricing

DoseSelf-Pay Price
  • 0.8 mg$149
  • 2.5 mg$149
  • 5.5 mg$199
  • 9 mg$299
  • 14.5 mg$299
  • 17.2 mg$299

Prescription required • Eligibility determined after medical evaluation

Injection Options

Wegovy® Injection

Semaglutide • GLP-1

Once-weekly prescription injection for weight management.

Available Doses & Self-Pay Pricing

DoseSelf-Pay Price
  • 0.25 mg$199
  • 0.5 mg$199
  • 1 mg$349
  • 1.7 mg$349
  • 2.4 mg$349
  • 2.4 mg (Wegovy® HD)$399

Prescription required • Eligibility determined after medical evaluation

Zepbound®

Tirzepatide • GIP + GLP-1

Once-weekly prescription injection for weight management.

Available Doses & Self-Pay Pricing

DoseSelf-Pay Price
  • 2.5 mg$299
  • 5 mg$399
  • 7.5 mg$449
  • 10 mg$449
  • 12.5 mg$449
  • 15 mg$449

Prescription required • Eligibility determined after medical evaluation

Prescription medications require medical evaluation and are prescribed only when clinically appropriate. Medication availability and self-pay pricing may change. Individual results vary.

Kasorn Wellness Clinic

$250 Initial Consultation + $99/month Medication Management

Medication and lab costs are separate.

Labs

Recent labs within the past 12 months are required.

Existing recent labs may be submitted for review.

BMI Calculator

Height

Weight

Your BMI

—

Standard BMI

  • Underweight< 18.5
  • Healthy18.5–24.9
  • Overweight25.0–29.9
  • Obesity≥ 30.0

Asian BMI

  • Underweight< 18.5
  • Healthy18.5–22.9
  • Increased Risk23.0–24.9
  • Obesity / Higher Risk≥ 25.0

BMI is a screening tool. BMI risk thresholds may differ for Asian populations and do not determine treatment eligibility by themselves.

Mounjaro® vs. Zepbound®

Mounjaro®

Tirzepatide • GIP + GLP-1

FDA-approved use: Type 2 diabetes

Zepbound®

Tirzepatide • GIP + GLP-1

FDA-approved use includes chronic weight management

Same Active Ingredient. Different FDA-Approved Uses.

Mounjaro® = Tirzepatide  •  Zepbound® = Tirzepatide

Prefer customized dosing?

All-inclusive compounded GLP-1 and GLP-1/GIP programs.

See Custom-Dose Medications

Begin

Ready to Get Started?

Schedule your virtual consultation with Kasorn Wellness Clinic and start your personalized wellness journey today.

Book Consultation